{4-[(Methylsulfonyl)oxy]phenyl}acetic acid, 97%, 100mg

N-4-Cbz-Piperazine-2-carboxylate methyl ester, 95.0%, 5g

1-(3-Bromo-5-nitrophenyl)ethanone, 95.0%, 250mg

Cyclohexanamine, 4-(2-methoxyethoxy)-, trans- (9CI), 95.0%, 5g

6-Bromo-2-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrazine, 97%, 1g

2-Amino-6-methylheptane, 98.0%, 5g

Cephalotaxine, 95.0%, 250mg

2,6-Bis((R)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)pyridine, 98.0%, 100mg

Azepane-2,4-dione, 95.0%, 250mg

4-Ethynyl-1,4-dihydro-8-methyl-1-[(4-methylphenyl)sulfonyl]-2H-3,1-benzoxazin-2-one, 25mg

Ethyl 2-(2-bromoimidazo[2,1-b][1,3,4]thiadiazol-6-yl)acetate, 95%, 1g

Éter monometílico de tripropilenglicol, min 97%, para síntesis, 1L, envase de plástico.

4-Cyclopropyl-[1,2,3]thiadiazole-5-carboxylic acid, 95.0%, 5g